6CM
683 Capital Management Portfolio holdings
AUM
$986M
1-Year Return
26.79%
This Quarter Return
+4.39%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$987M
AUM Growth
-$41.8M
(-4.1%)
Cap. Flow
-$68.6M
Cap. Flow
% of AUM
-6.95%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
172
New
17
Increased
22
Reduced
26
Closed
25
Top Buys
| 1 |
SharkNinja
SN
|
$30.1M |
| 2 |
GE HealthCare
GEHC
|
$28.9M |
| 3 |
NCR Voyix
VYX
|
$16.2M |
| 4 |
XHR
Xenia Hotels & Resorts
XHR
|
$16M |
| 5 |
Phinia Inc
PHIN
|
$13.4M |
Top Sells
| 1 |
CNDA
Concord Acquisition Corp II
CNDA
|
$25.4M |
| 2 |
HES
Hess
HES
|
$19.1M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$17.3M |
| 4 |
Enova International
ENVA
|
$12.7M |
| 5 |
Noble Corp
NE
|
$11.7M |
Sector Composition
| 1 | Healthcare | 22.67% |
| 2 | Consumer Discretionary | 19.26% |
| 3 | Financials | 16.85% |
| 4 | Energy | 6.73% |
| 5 | Materials | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Protagonist Therapeutics
PTGX
$3.61B
| $12.2M | 0.95% |
732,784
-81,216
| -10% | -$1.35M |
|
27
MeiraGTx Holdings
MGTX
$591M
| $12.1M | 0.94% |
2,457,609
| – | – |
|
28
Western Alliance Bancorporation
WAL
$10B
| $11.5M | 0.89% |
250,000
-50,000
| -17% | -$2.3M |
|
29
Harmony Biosciences
HRMY
$2.11B
| $11.5M | 0.89% |
350,000
+50,000
| +17% | +$1.64M |
|
30
Phathom Pharmaceuticals
PHAT
$800M
| $11.4M | 0.89% |
1,100,000
-187,500
| -15% | -$1.94M |
|
31
TG Therapeutics
TGTX
$4.96B
| $11.3M | 0.88% |
+1,350,000
| New | +$11.3M |
|
32
Garrett Motion
GTX
$2.63B
| $11M | 0.86% |
+1,400,000
| New | +$11M |
|
33
uniQure
QURE
$931M
| $10.6M | 0.82% |
1,575,000
+280,000
| +22% | +$1.88M |
|
34
Citigroup
C
$177B
| $9.38M | 0.73% |
228,000
+78,000
| +52% | +$3.21M |
|
|
CRESY
35
Cresud
CRESY
$588M
| $9.37M | 0.73% |
1,413,797
+808
| +0.1% | +$5.35K |
|
36
Iovance Biotherapeutics
IOVA
$774M
| $9.33M | 0.73% |
2,050,000
+650,000
| +46% | +$2.96M |
|
37
Teck Resources
TECK
$15.6B
| $9.26M | 0.72% |
215,000
| – | – |
|
38
Apellis Pharmaceuticals
APLS
$3.48B
| $9.13M | 0.71% |
240,000
+195,700
| +442% | +$7.44M |
|
|
ITOS
39
DELISTED
iTeos Therapeutics
ITOS
| $8.87M | 0.69% |
810,000
+225,000
| +38% | +$2.46M |
|
40
Sea Limited
SE
$111B
| $8.79M | 0.68% |
+200,000
| New | +$8.79M |
|
41
KNOT Offshore Partners
KNOP
$283M
| $7.83M | 0.61% |
1,146,501
+146,501
| +15% | +$1M |
|
|
MREO
42
Mereo BioPharma
MREO
$269M
| $7.74M | 0.6% |
6,000,000
+600,000
| +11% | +$774K |
|
|
HES
43
DELISTED
Hess
HES
| $7.65M | 0.59% |
50,000
-125,000
| -71% | -$19.1M |
|
44
Frontier Communications
FYBR
$9.3B
| $7.04M | 0.55% |
+450,000
| New | +$7.04M |
|
45
InflaRx
IFRX
$108M
| $7M | 0.54% |
2,350,000
+350,000
| +18% | +$1.04M |
|
46
Viking Therapeutics
VKTX
$2.93B
| $6.92M | 0.54% |
625,000
+45,000
| +8% | +$498K |
|
47
Invivyd
IVVD
$209M
| $6.8M | 0.53% |
4,000,000
| – | – |
|
48
Alibaba
BABA
$314B
| $5.64M | 0.44% |
+65,000
| New | +$5.64M |
|
|
ARMN
49
Aris Mining
ARMN
$1.82B
| $5.27M | 0.41% |
+2,315,900
| New | +$5.27M |
|
|
BHAC
50
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
| $5.26M | 0.41% |
500,000
| – | – |
|